Uncategorized
Leber's Hereditary Optic Neuropathy (Leber Optic Atrophy) Pipeline Review, H2 2020 – Therapeutic Assessment of 14 Companies, Drug Profiles, Dormant Projects, Product Development Milestones – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Leber's Hereditary Optic Neuropathy (Leber Optic Atrophy) - Pipeline Review, H2 2020" drug pipelines has been added to ResearchAndMarkets.com's offering. Leber's Hereditary Optic Neuropathy - Pipeline Review, H2 2020, provides comprehensive information on the therapeutics under development for Leber's Hereditary Optic Neuropathy (Ophthalmology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and